EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Altered Dopamine Metabolism and Response to Treatment with Levodopa/Carbidopa in MCT8 Deficiency

Fabio Bruschi iD, Ylenia Vaia, Clara E Antonello, Marco Spada, Francesco Porta, Cristina Marinaccio, Claudia Carducci, Thomas Opladen, Jacopo Sartorelli, Federica Maria Zibordi, Daniele Ghezzi, Francesco Nicita und 1 weitere

Movement Disorders · 2025

DOI: 10.1002/mds.70093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Fabio Bruschi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Pediatric Neurology, COALA (Center for Diagnosis and Treatment of Leukodystrophies), V. Buzzi Children's Hospital, Milan, Italy. Hauptthemen laut MEDLINE: Levodopa, Carbidopa, Dopamine, Muscle Hypotonia. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Allan‐Herndon‐Dudley syndrome (AHDS)/monocarboxylate transporter 8 (MCT8) deficiency is a rare X‐linked encephalopathy caused by SLC16A2 variants, impairing thyroid hormone (TH) transport into the brain. This leads to early central nervous system (CNS) TH deficiency, affecting brain maturation. Dopaminergic circuit involvement is suggested by both pathophysiology and clinical features, reminiscent of infantile parkinsonism.

Objective

This study investigates dopamine metabolism and levodopa/carbidopa response in MCT8 patients.

Methods

We retrospectively and prospectively collected clinical, genetic, and neuroimaging data, performed cerebrospinal fluid (CSF) biogenic amine analyses, and conducted neurological assessments before and after the levodopa trial (10 mg/kg/day).

Results

Ten patients exhibited developmental delay, spasticity, and infantile parkinsonism. CSF analysis showed reduced homovanillic acid in 3/10 patients, with 7/10 in the lowest quartile. Levodopa improved parkinsonism and reactivity in 7/10 patients.

Conclusions

Our findings confirm dopaminergic involvement in AHDS and show that levodopa/carbidopa effectively treats extrapyramidal symptoms. Further investigations could differentiate presynaptic and postsynaptic defects to optimize dopaminergic therapy. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevodopaCarbidopaDopamineMuscle HypotoniaX-Linked Intellectual DisabilityMonocarboxylic Acid TransportersSpasms, InfantileAntiparkinson AgentsHumansMaleFemaleDrug CombinationsChild, PreschoolChildRetrospective StudiesInfantSymportersHomovanillic AcidAdolescentMuscular Atrophy

Stichwörter der Autor:innen

Allan‐Herndon‐Dudley syndromeMCT8SLC16A2dystoniahypothyroidismneurotransmitterparkinsonism

Substanzen

LevodopaCarbidopaDopaminecarbidopa, levodopa drug combinationDrug CombinationsMonocarboxylic Acid TransportersSymportersHomovanillic AcidAntiparkinson Agents

Autor:innen und Institutionen

  • Unit of Pediatric Neurology, COALA (Center for Diagnosis and Treatment of Leukodystrophies), V. Buzzi Children's Hospital, Milan, Italy.
  • Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, Milan, Italy.
  • Department of Pediatrics, University of Torino, Torino, Italy.
  • Department of Clinical and Biological Sciences, University of Torino, Torino, Italy.
  • Child and Adolescence Neuropsychiatry Service, Department of Child Pathology and Cure, Regina Margherita Children's Hospital, Turin, Italy.
  • Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.

ORCID-Profile: Fabio Bruschi

Zitieren

APA

Bruschi, F., Vaia, Y., Antonello, C. E., Spada, M., Porta, F., Marinaccio, C., Carducci, C., Opladen, T., Sartorelli, J., Zibordi, F. M., Ghezzi, D., Nicita, F., & Tonduti, D. (2025). Altered Dopamine Metabolism and Response to Treatment with Levodopa/Carbidopa in MCT8 Deficiency. Movement Disorders. https://doi.org/10.1002/mds.70093

Vancouver

Bruschi F, Vaia Y, Antonello CE, Spada M, Porta F, Marinaccio C, et al. Altered Dopamine Metabolism and Response to Treatment with Levodopa/Carbidopa in MCT8 Deficiency. Movement Disorders. 2025. doi:10.1002/mds.70093

BibTeX
@article{Bruschi2025,
  author = {Bruschi, Fabio and Vaia, Ylenia and Antonello, Clara E and Spada, Marco and Porta, Francesco and Marinaccio, Cristina and Carducci, Claudia and Opladen, Thomas and Sartorelli, Jacopo and Zibordi, Federica Maria and Ghezzi, Daniele and Nicita, Francesco and Tonduti, Davide},
  title = {Altered Dopamine Metabolism and Response to Treatment with Levodopa/Carbidopa in MCT8 Deficiency},
  journal = {Movement Disorders},
  year = {2025},
  doi = {10.1002/mds.70093}
}
Kostenlos starten →